Skyline is a spin-off company from Erasmus University Medical Center in Rotterdam. The company develops and commercialises advanced diagnostic tools using microarray technology for oncology serving a global market. This ambitious goals can be reached in collaboration with several large industrial and world re-known academic partners. Skyline uses the extremely robust and reliable microarray platform of Affymetrix (USA) for which the company acquired the appropriate licenses and develops the essential ICT infrastructure with Atos Origin and Crosslinks (the Netherlands). The company has 4 products in development for Acute Myeloid Leukemia (AML), Multiple Myeloma (MM), Oligodendroglioma (OGD) and Acute Lymphoid Leukemia.

Speaker Profile

Henk Viëtor, MD PhD, CEO

Henk Viëtor, MD PhD (CEO), specialized in Clinical Genetics. He became involved in the life sciences industry in 2001. He is an active entrepreneur in this industry and is founder and shareholder of several biotech spin-off companies including Immunaffect, Recharge, Drug Discover Factory, DC4U and DCPrime.